Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW
19,740
+940 (5.00%)
Mar 10, 2026, 11:20 AM KST
Onconic Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 843,891 | 176,537 | - | - | - |
| Enterprise Value | 790,477 | 152,373 | - | - | - |
| Last Close Price | 18800.00 | 4085.00 | - | - | - |
| PS Ratio | 18.09 | 11.90 | - | - | - |
| PB Ratio | 12.25 | 3.15 | - | - | - |
| P/TBV Ratio | 12.25 | 3.15 | - | - | - |
| EV/Sales Ratio | 16.94 | 10.27 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.01 | -0.06 | 0.00 | -0.02 |
| Debt / EBITDA Ratio | 0.01 | - | 0.13 | - | - |
| Debt / FCF Ratio | 0.02 | - | 0.12 | - | - |
| Net Debt / Equity Ratio | -0.77 | -0.76 | 5.05 | 1.24 | 2.34 |
| Net Debt / EBITDA Ratio | -4.13 | 9.82 | -11.05 | 1.85 | 2.25 |
| Net Debt / FCF Ratio | -7.54 | 5.35 | -9.97 | 1.56 | 2.11 |
| Asset Turnover | 0.87 | 0.30 | 0.62 | 0.00 | - |
| Quick Ratio | 12.64 | 10.61 | 0.71 | 1.06 | 36.08 |
| Current Ratio | 13.21 | 10.94 | 0.71 | 1.06 | 36.10 |
| Return on Equity (ROE) | 33.75% | -32.29% | - | - | - |
| Return on Assets (ROA) | 14.36% | -6.09% | 4.07% | -36.85% | - |
| Return on Capital Employed (ROCE) | 18.00% | -8.50% | -39.40% | -343.70% | -44.10% |
| Earnings Yield | 1.99% | -4.58% | - | - | - |
| FCF Yield | 0.84% | -4.52% | - | - | - |
| Buyback Yield / Dilution | - | -41.46% | 0.00% | -0.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.